Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LDL Cholesterol”

507 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 507 results

Not applicableStudy completedNCT01483950
What this trial is testing

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Post-approval studies (Phase 4)UnknownNCT03277079
What this trial is testing

Low Dose Statins, Ezetimibe and Nutraceuticals

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 100
Post-approval studies (Phase 4)Study completedNCT00644670
What this trial is testing

The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 232
Not applicableStudy completedNCT03903029
What this trial is testing

Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline

Who this might be right for
Dyslipidemias
Seoul National University Hospital 242
Not applicableLooking for participantsNCT06231966
What this trial is testing

Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

Who this might be right for
Peripheral Artery DiseasePolyvascular Disease
Yonsei University 2,462
Large-scale testing (Phase 3)Study completedNCT00654602
What this trial is testing

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Who this might be right for
Dyslipidaemia
AstraZeneca 1,500
Not applicableStudy completedNCT00999453
What this trial is testing

The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients

Who this might be right for
Hypercholesterolemia
Clinical Research Center for End Stage Renal Disease, Korea 43
Not applicableStudy completedNCT00804427
What this trial is testing

Effect of Fish Oil on Plasma Triglycerides in Adults

Who this might be right for
Hypertriglyceridemia
Stanford University 60
Testing effectiveness (Phase 2)Study completedNCT00231569
What this trial is testing

Dose-escalating Safety Study in Subjects on Stable Statin Therapy

Who this might be right for
Hypercholesterolemia
Kastle Therapeutics, LLC 74
Large-scale testing (Phase 3)Study completedNCT01483560
What this trial is testing

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

Who this might be right for
Diabetes Mellitus, Type 1
University of Glasgow 493
Early research (Phase 1)Study completedNCT02314442
What this trial is testing

An Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Alnylam Pharmaceuticals 70
Early research (Phase 1)Study completedNCT00055042
What this trial is testing

Laser and Antioxidant Treatment of Diabetic Macular Edema

Who this might be right for
Macular EdemaDiabetes Mellitus
National Eye Institute (NEI) 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Testing effectiveness (Phase 2)Study completedNCT02659397
What this trial is testing

Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg

Who this might be right for
Hyperlipidemia
Esperion Therapeutics, Inc. 68
Not applicableStudy completedNCT03527277
What this trial is testing

Orange Juice And Sugar Intervention Study

Who this might be right for
Cardiovascular Risk FactorType2 Diabetes MellitusInsulin Sensitivity+1 more
University of California, Davis 56
Post-approval studies (Phase 4)Study completedNCT00166530
What this trial is testing

EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)

Who this might be right for
Atherosclerosis
Organon and Co 367
Testing effectiveness (Phase 2)Study completedNCT04992065
What this trial is testing

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novo Nordisk A/S 267
Testing effectiveness (Phase 2)Study completedNCT01351025
What this trial is testing

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 98
Not applicableUnknownNCT04087915
What this trial is testing

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD)

Who this might be right for
DyslipidemiaHigh Risk Coronary Artery Disease
Beijing Anzhen Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT00283335
What this trial is testing

The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol

Who this might be right for
Coronary Heart Disease
VA Office of Research and Development 2,531
Load More Results